Renew31 benefits: what is claimed, and what the sources publish

Part A

What the product is sold as, and what the label prints

On most products the advert, the bottle and the sources say roughly the same thing in three registers. Here they do not meet, and keeping them apart is most of the work of this page.

Renew31 is sold as gut and inner-nutrition support. A category is not an outcome: it says where a product sits on a shelf rather than what it will do to anybody. The panel carries no benefit line of any kind, no asterisked support claim and no sentence that would need a source behind it. That is worth crediting: a label promising less than its advert has promised less.

• The category, as the product is sold. Gut and inner-nutrition support. No outcome and no timeline attached to it in any material supplied with this stock.
• The label’s own words. A panel, an ingredient list and an allergen line.
• The sources. Three botanicals have an NCCIH finding and none has a published dose. Six of the ten things this label declares are addressed by no federal health agency this desk could open. That is not a verdict on them. It is the state of what could be read.
• The finished formula. No published trial on Renew31 itself was supplied, and none appears in any source this desk opened.

Part B

What a structure and function claim is, and is not

The phrase this product is sold under belongs to a category of wording with rules of its own, and the rules are narrower than most readers assume.

Part C

Every published finding that touches this label

Four of the ten declared things have a finding in a federal source this desk opened. Here are all four, with the position the printed order gives them.

Three of those rows have the same shape, and it is not the shape a claims page usually prints. NCCIH on fenugreek: “There is not enough high-quality evidence to determine whether fenugreek is useful for diabetes or menstrual cramps.” ^NCCIH On dandelion: “There’s no compelling scientific evidence supporting the use of dandelion for any health condition.” ^NCCIH And behind it: “We know very little about dandelion’s effect on human health.” ^NCCIH Those are the summary sentences of federal fact sheets, and a claims page that left them out would be dishonest by omission.

The ginger row reads differently and is the most easily misused. “Research shows that ginger may be helpful for nausea and vomiting associated with pregnancy.” ^NCCIH That is a real finding about nausea and vomiting associated with pregnancy, which is not what this product is sold for, and NCCIH publishes no dose for it. The fourth row is the only one with a dose, and the endpoint is the thing to read. One caution travels with that comparison wherever it goes. The effect FDA recognised in that review is on bone mineral density and the absorption of calcium. It is not a gut finding, and no page here cites it as one.

Six of the ten things this label declares are addressed by no federal health agency this desk could open. That is not a verdict on them. It is the state of what could be read. On a claims page that absence has particular weight. Where an agency has published a negative finding, a seller who claims an outcome is contradicted by a source. Where an agency has published nothing, such a claim cannot be contradicted at all, and neither can it be supported. This site never cites PubMed or PMC as a federal finding. The National Library of Medicine runs the index; the papers in it are third-party work. Where an agency has published nothing, this site says it has published nothing.

Part D

What this page will not say, and why

Four sentences a page like this usually carries. None appears anywhere on this site, and each is left out for a reason a reader can check.

• It will not say the product works. No published trial on the finished Renew31 formula was supplied with this stock, and none appears in any source this desk opened. Every reference here describes one ingredient, a category, or a labelling regulation.
• It will not say the product does not work. The same absence cuts both ways.
• It will not compare this product with another. A reader here cannot see any other product, so the comparison could not be checked.
• It will not give a timeline. the timeline page sets out why.

In one paragraph

Renew31 is sold as gut and inner-nutrition support, which is a category rather than a promise, and the panel claims nothing at all. Four of the ten declared things have a published federal finding; in two of the four the finding is that the evidence is not there, in one it concerns an endpoint this product is not sold for, and in the fourth it concerns bone mineral density and calcium absorption at an intake 7 times the whole blend. No dose is published for three of those four. Six of the ten things this label declares are addressed by no federal health agency this desk could open. That is not a verdict on them. It is the state of what could be read. Read the cautions page first if you have a severe illness or a compromised immune system, if you are pregnant or might be, or if you take prescription medicine.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.